Notably, our analysis of data from Fudan University revealed that high IGFBP4 expression was a protective factor for tumor chemotherapy, implying that IGFBP4 can be used to guide postoperative chemotherapy [32] (Fig. 3m). The gene discussed is IGFBP4; the disease is neoplasm.